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Cancer appearance in some inherited diseases depends on the interactions with other genes. Lung cancer is rare in
neurofibromatosis and has not been reported in Caucasian population. In this paper, we present the case of lung
adenocarcinoma in a patient with neurofibromatosis, pseudoarthrosis of tibia, and autosomal dominant polycystic kid-
ney disease. Cytogenetic analysis of the pleural effusion showed chaotic cleavage and constitutional inversion of chro-
mosome 9, transmitted from the mother. Family investigation revealed two autosomal dominant diseases, neuro-
fibromatosis and polycystic kidney disease in the same family. These findings suggest that the second autosomal
dominant disease in the family and inversion of chromosome 9 contributed to the severity of neurofibromatosis and pa-
tient’s risk to malignancies.
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Neurofibromatosis 1, or Morbus von Reckling-
hausen, is a relatively common autosomal dominant
disease, which affects approximately one in 3,500
newborns (1). It is mostly a progressive disease, but
with variable expression. The consistent clinical fea-
tures of neurofibromatosis 1 are neurofibromas, café
au lait spots, and Lisch nodules or pigmented iris
hamartomas. Except these defining features, there are
many other characteristics of this disease (2). Malig-
nant tumors are more common in patients with
neurofibromatosis than in population at large. The
mean age of patients with neurofibromatosis 1 at di-
agnosis of malignancy is 38 years, compared with a
mean age of 65 of the general population in the
United States (2). Common malignancies in neurofib-
romatosis 1 patients are neurofibrosarcoma, optic gli-
oma, malignant schwannoma, Wilms’ tumor, rhabdo-
myosarcoma, astrocytoma, neuroblastoma, pheo-
chromocytoma, leiomyosarcoma, and some types of
leukemia (3). The development of epithelial malig-
nancies, such as thyroid carcinoma, lung cancer, car-
cinoma of the Vater’s ampulla, breast, bladder, or co-
lon cancer is rare (4-6). Neurofibromatosis (NF) 1
gene is widely expressed in many tissues, and at par-
ticularly high level in the central and peripheral ner-
vous system (7). It is assumed that the product of NF 1
gene, neurofibromin, acts as a tumor suppressor by
inhibiting the activity of ras oncogene (8). Besides
germline mutations in NF 1 gene, other mutations can
also occur in somatic cells and contribute to the de-
velopment of sporadic tumors, including tumors
without association with NF 1 (9-11).
Autosomal dominant polycystic kidney disease
has a prevalence of about 1:1,000 (12) and may occur
at any time in life. It is characterized by cystic forma-
tion of the kidney and, to a lesser extent, of the liver,
spleen, pancreas, lungs, uterus, and several other or-
gans, as well as of the testis and epididymis (13-15).
Other gastrointestinal, cerebrovascular, and cardio-
vascular abnormalities are often found in patients
with autosomal dominant polycystic kidney disease.
In the majority of affected families, autosomal domi-
nant polycystic kidney disease is linked to PKD 1
gene on chromosome 16p (16). PKD 1 mutations de-
fine a classical form of the disease, also known as
autosomal dominant polycystic kidney disease 1.
Here we present a patient with neurofibromatosis
combined with lung adenocarcinoma and pseudo-
arthrosis of the tibia.
Case Report
A 50-year-old white male was admitted to the
Department of Pulmology for a chest pain on the right
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side, cough, dyspnea, fever, and weight loss. His past
medical history included congenital deformation of
the right foot. Skin macular pigmentation and neuro-
fibromas, first observed at the age of 13, increased in
number and size. His mother, aunt, and grandfather
from the mother’s side, had similar skin changes, but
smaller and fewer. His uncle underwent a surgical
treatment for kidney polycystosis, whereas his sister
has kidney cysts and her daughter a polycystic ovary
(Fig. 1). Proband’s mother and aunt, both with neuro-
fibromatosis, had surgically treated myoma and stom-
ach carcinoma, respectively. At physical examina-
tion, the patient showed multiple neurofibromas and
café au lait spots (Fig. 2) covering the whole body,
particularly the trunk. The right tibia was 8 cm shorter
than the left one, with hypothrophic musculature, and
the right ankle was deformed, with 0 degrees of
flexion and 15 degrees of extension.
The chest radiograph revealed massive pleural
effusion, totally shaded right lung. Computed tomog-
raphy (CT) scan of the chest revealed a large mass, 8.2
cm in diameter, in the right upper lobe, with central
necrosis, liquidopneumothorax, and limited effusion
on the same side, multiple nodular right pleural infil-
trates specific for the pleural metastases, and an ab-
normal enlargement of the lymph nodes in the right
supraclavicular and left axial region.
Pleural fluid had characteristics of an exudate
and contained adenocarcinoma cells, as revealed on
cytological examination. Malignant cells were not
found on the cytological examination of broncho-
scopic specimens, but the biopsy of the tumor by
transthoracic ultrasound-guided needle showed ma-
lignant adenocarcinoma cells. CT scan of the brain re-
vealed a tumor with level of density consistent to the
metastases and necrosis at the right frontoparietal re-
gion. Therefore, the stage of the lung adenocarcino-
ma was specified as T4N3M1.
Abdominal ultrasound of the right kidney re-
vealed a focal mass 8.5 x 5.6 cm and a cyst of 4.6 cm
in diameter. Excretory urography confirmed a tumor.
Unfortunately, the patient refused renal biopsy and
the exact origin of the tumor could not be confirmed.
Radiography of the right ankle showed aplasia of the
distal part of the fibula, inclined and deformed tibia,
and demineralized bones of the foot. Orthopedic di-
agnosis was congenital hypoplasia of the right fibula
and congenital pseudoarthrosis of the right tibia.
Histopathological examination of the skin nodule bi-
opsy confirmed neurofibroma.
Karyotype analyses were performed on lympho-
cyte cultures from the patient and his mother. Pleural
effusion cells of the patient were cultured for 10 days.
Metaphase chromosomes were GTG-banded (17).
Cytogenetic findings of the long-term cultivated pleu-
ral effusion cells showed chaotic cleavage. The most
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Figure 2. Patient with neurofibromatosis. The entire trunk is
covered with cutaneous tumors.
Figure 1. Pedigree of the family with neurofibromatosis (NF) 1. Arrow indicates the proband; open square – unaffected male;
open circle – unaffected female; closed square – male affected by NF1 and polycystic kidney disease (PKD); closed circle –
female affected by NF1 and PKD; open-closed square – male affected by NF1; open-closed circle – female affected by NF1;
square with a question mark – possibly affected male; circle with a question mark – possibly affected female; open circle with
a closed triangle – female with polycystic ovaries; closed-open square – male affected with PKD; closed-open circle – female
affected with PKD; open square with a cross – deceased male; open circle with a cross – deceased female.
common chromosome modal number in tumor cell
population was 4n±. Unbalanced forms of various
translocations involving long arms of chromosomes
1, 3, and 10, marker, dicentric, and ring chromoso-
mes, were seen in each metaphase spread, although
there were a few mitoses with normal number of
chromosomes but pericentric inversion transmitted
from the mother – 46,XY,inv(9)(p11q13). Due to
great karyotypic heterogeneity within the pleural effu-
sion cells, a composite karyotype had to be created:
92,XXYY,inv(9)(p11q13)c,+1,+3,+7,+dic(1;?),+
3mar,-9,-17 [cp17].
A palliative radiotherapy of the lung cancer was
performed. Patient died two months later, at the age
of 50.
Discussion
We presented a patient with Recklinghausen’s
disease who had lung adenocarcinoma and pseudo-
arthrosis, both very rare diseases in neurofibroma-
thosis. He also had polycystic kidney disease and in-
version of the chromosome 9 heterochromatin re-
gion. The coexistence of two autosomal dominant
diseases, found in his family, is also extremely rare.
NF 1 gene spans over 350 kb of genomic DNA in
the chromosomal region 17q11.2 (near centromere)
and is widely expressed in a variety of human tissues.
As mutations of the NF 1 gene have been detected in
tumors, the presumption is that NF 1 belongs to the
family of tumor suppressor genes (11,18). The trans-
located chromosomes have chromosome 17 break-
points at the exact location where the NF 1 gene has
been mapped (1). Neurofibromatosis is one of the
most common human mutations, with average inci-
dence of approximately 4/100,000 gametes (1,19).
About half of all cases are considered to be the result
of a new mutation. One of the most common human
genetic diseases is autosomal dominant polycystic
kidney disease 1 (12). From that aspect, it is not
strange to find both diseases in one family.
Both sexes in Recklinghausen’s disease are af-
fected with equal frequency, with 50% recurrence
risk, pronouncedly variable expression, virtually
100% penetrance, and 25-30% risk for moderate or
severe disease, similar to polycystic kidney disease.
The severity of the Recklinghausen’s disease is unpre-
dictable. No relation was found between the severity
and age of onset, status of the affected parent, birth or-
der, parental age, or environmental factors (1).
Lung cancer appears rarely in Recklinghausen’s
disease. There have been only 14 cases of neurofibro-
matosis associated with lung cancer, and only in the
Japanese population (4,20,21). Adenocarcinoma was
observed in about 73% of these cases (20). Many au-
thors examined if genetic abnormality in neurofibro-
matosis increases a patient’s risk of malignancies.
Loss of heterozygosity (LOH) was detected on chro-
mosome arm 17p in a patient with small cell lung car-
cinoma, but it is still unknown whether a mutation of
the NF 1 gene on 17q was involved in the develop-
ment of small cell lung carcinoma (21). The cases of
Recklinghausen’s disease and lung cancer derived
from wall of emphysematous bulla have also been de-
scribed (19). In our patient’s family, the neurofibro-
matosis was connected with several malignancies:
stomach carcinoma (aunt, II:7; Fig. 1), lung adeno-
carcinoma, and possible kidney carcinoma (proband,
III:2; Fig. 1). NF 1 protein regulates the level of biolog-
ically active ras-GAP (11). Ras activity is associated
with the regulation of cell growth and differentiation
including control of cytoskeletal organization and
formation of cell-cell junction (8), possibly causing
multiple tumor changes.
Pseudoarthrosis appears in 0.5-3% of the pa-
tients with neurofibromatosis, and about 50% of all
cases of congenital pseudoarthrosis are due to neuro-
fibromatosis (22). The tibia and the radius are the
most common sites (23). The exact origin of pseudo-
arthrosis is unclear. Male patients have this complica-
tion more frequently than female ones. Moreover, this
feature is more common if the gene is transmitted
from the mother (22), as in our patient.
The inversion of the chromosome 9 is consid-
ered a normal heteromorphism, with familial inheri-
tance. It is the result of fragile region involving re-
peated , , and satellite III DNA sequences (24),
which gives rise to a variety of heteromorphisms
whose clinical significance remains obscure. Al-
though heterochromatin has been regarded as mean-
ingless filler in the genome, its rearrangement can al-
ter certain surrounding genes (25). 9p21 LOH has
been detected in 70% of the early stages of lung can-
cer (26). The interaction of the remaining allele oc-
curs through such processes as mutation or hyper-
methylation in cell clones in which exists an initial
mutation. The inversion of hypermethylated hetero-
chromatin near 9p21 loci is a highly possible mecha-
nism for LOH and an additional factor contributing to
malignancy in our patient. No clonal chromosomal
aberration was found in cytogenetic analysis of the
patient’s pleural effusion cells, although the aberra-
tions of chromosomes 9 and 3 are found. These chro-
mosomes have been demonstrated as LOH sites in
malignant lesion (27). Cysts of the testis, epididymis,
and seminal vesicles in patients with autosomal domi-
nant polycystic kidney disease have been reported
(14,15), but polycystic ovaries in patients with poly-
cystic kidney disease have not been described so far,
and only further genetic testing will prove if pro-
band’s niece (IV:2; Fig. 1) has PKD 1 gene mutation
transmitted from her mother.
In addition to lung adenocarcinoma and pseudo-
arthrosis, our patient with neurofibromatosis 1 also
had polycystic kidney disease, a second autosomal
dominant disease, and an inversion of chromosome 9
heterochromatin, which may have contributed to the
severity of neurofibromatosis and development of
multiple malignancies.
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